Home > Research > Researchers > Pavel Mozgunov

Pavel Mozgunov

Research Student

Research overview

  • I am an NIHR Fellow (Advanced Fellowship) working on the development and implementation of (response-) adaptive designs in clinical trials.

  • I provide statistical support in a number of trials (both publically and privately funded), including AGILE-ACCORD (https://www.agiletrial.net/), an early phase trial studying novel therapies for COVID-19 treatments.
  • If you believe that the trial(s) you are planning can benefit from an adaptive design, feel free to reach me for the discussion - I will be happy to help.
  • I also collaborate with a number of pharmaceutical companies on developing novel adaptive designs and their implementations in ongoing privately funded clinical trials.

Research Grants

  • PI: NIHR Advanced Fellowship: Bringing Innovative Methods for Early Phase Precision Medicine Trials Into Practice (BINOP), NIHR
  • Co-I: COVID 19 - AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment, Wellcome Trust
  • Co-I: FORWARDS: Facilitating Opiate Recovery: Withdrawal and Abstinence through Detoxification Support, MRC

View all (20) »